{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:37:51Z","timestamp":1788417471826,"version":"build-2803163510"},"reference-count":61,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","seminarsinnephrology.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.semnephrol.2016.05.019","type":"journal-article","created":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T06:30:27Z","timestamp":1477031427000},"page":"428-434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Not the Usual Viral Suspects: Parvovirus B19, West Nile Virus, and Human T-Cell Lymphotrophic Virus Infections After Kidney Transplantation"],"prefix":"10.1016","volume":"36","author":[{"given":"Raymund R.","family":"Razonable","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 4","key":"10.1016\/j.semnephrol.2016.05.019_bib1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/ajt.12111","article-title":"Human parvovirus B19 in solid organ transplantation","volume":"13","author":"Eid","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jcv.2013.07.007","article-title":"Low-level DNAemia of parvovirus B19 (genotypes 1-3) in adult transplant recipients is not associated with anaemia","volume":"58","author":"Plentz","year":"2013","journal-title":"J Clin Virol"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1099\/00222615-25-2-151","article-title":"The prevalence of antibody to human parvovirus B19 in England and Wales","volume":"25","author":"Cohen","year":"1988","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4103\/1319-2442.124465","article-title":"The seroprevalence of Parvovirus B19 among kidney transplant recipients: a single-center study","volume":"25","author":"Khameneh","year":"2014","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1423-0410.1998.7520097.x","article-title":"Human parvovirus B19: prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients","volume":"75","author":"Jordan","year":"1998","journal-title":"Vox Sang"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib6","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1365-2141.1995.tb05427.x","article-title":"Incidence of human parvovirus B19 DNA detection in blood donors","volume":"91","author":"Yoto","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib7","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1086\/644504","article-title":"Detection of viral DNA in kidney graft preservation and washing solutions is predictive of posttransplant infections in pediatric recipients","volume":"200","author":"Barzon","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib8","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1399-0012.2005.00415.x","article-title":"Incidence and clinical significance of human parvovirus B19 infection in kidney transplant recipients","volume":"19","author":"Ki","year":"2005","journal-title":"Clin Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib9","doi-asserted-by":"crossref","first-page":"102829","DOI":"10.1100\/2012\/102829","article-title":"Parvovirus B19 infection and severe anemia in renal transplant recipients","volume":"2012","author":"Carraturo","year":"2012","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib10","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/jmv.23557","article-title":"Frequent occurrence of parvovirus B19 DNAemia in the first year after kidney transplantation","volume":"85","author":"Porignaux","year":"2013","journal-title":"J Med Virol"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1432-2277.2008.00818.x","article-title":"Clinical implications of quantitative real time-polymerase chain reaction of parvovirus B19 in kidney transplant recipients - a prospective study","volume":"22","author":"Park","year":"2009","journal-title":"Transpl Int"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/infdis\/154.3.383","article-title":"The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease)","volume":"154","author":"Chorba","year":"1986","journal-title":"J Infect Dis"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib13","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/archinte.1989.00390050111022","article-title":"Clinical manifestations of human parvovirus B19 in adults","volume":"149","author":"Woolf","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1086\/504812","article-title":"Parvovirus B19 infection after transplantation: a review of 98 cases","volume":"43","author":"Eid","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib15","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1399-3046.2006.00599.x","article-title":"Severe parvovirus B19 encephalitis after renal transplantation","volume":"10","author":"Laurenz","year":"2006","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib16","doi-asserted-by":"crossref","first-page":"E64","DOI":"10.1111\/j.1399-3062.2012.00773.x","article-title":"How many times can parvovirus B19-related anemia recur in solid organ transplant recipients?","volume":"14","author":"Gosset","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib17","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1126\/science.286.5448.2333","article-title":"Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States","volume":"286","author":"Lanciotti","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.TP.0000101435.91619.31","article-title":"Community-acquired West Nile virus infection in solid-organ transplant recipients","volume":"77","author":"Kumar","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib19","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/01.TP.0000438621.81686.ab","article-title":"West Nile virus infection in kidney and pancreas transplant recipients in the Dallas-Fort Worth Metroplex during the 2012 Texas epidemic","volume":"97","author":"Yango","year":"2014","journal-title":"Transplantation"},{"issue":"Suppl","key":"10.1016\/j.semnephrol.2016.05.019_bib20","doi-asserted-by":"crossref","first-page":"S678","DOI":"10.1097\/01.CCM.0000100124.50579.D9","article-title":"Risks of blood transfusion","volume":"31","author":"Goodnough","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib21","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1046\/j.1537-2995.2003.00481.x","article-title":"West Nile virus infection transmitted by blood transfusion","volume":"43","author":"Harrington","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib22","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1056\/NEJMoa030969","article-title":"Transmission of West Nile virus through blood transfusion in the United States in 2002","volume":"349","author":"Pealer","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib23","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00062752-200311000-00003","article-title":"Risks of transfusion-transmitted infections: 2003","volume":"10","author":"Pomper","year":"2003","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib24","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/TP.0b013e31829b4142","article-title":"Fatal transplant-associated West Nile virus encephalitis and public health investigation-California, 2010","volume":"96","author":"Rabe","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib25","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1056\/NEJMoa022987","article-title":"Transmission of West Nile virus from an organ donor to four transplant recipients","volume":"348","author":"Iwamoto","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib26","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/TP.0000000000000024","article-title":"Donor-derived West Nile virus infection in solid organ transplant recipients: report of four additional cases and review of clinical, diagnostic, and therapeutic features","volume":"97","author":"Winston","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib27","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s15010-012-0263-4","article-title":"West Nile virus transmission through organ transplantation in north-eastern Italy: a case report and implications for pre-procurement screening","volume":"40","author":"Inojosa","year":"2012","journal-title":"Infection"},{"issue":"Suppl 4","key":"10.1016\/j.semnephrol.2016.05.019_bib28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/ajt.12128","article-title":"Arenavirus and West Nile virus in solid organ transplantation","volume":"13","author":"Singh","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib29","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1399-3062.2009.00464.x","article-title":"Seroprevalence of West Nile virus infection in solid organ transplant recipients","volume":"12","author":"Freifeld","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib30","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1111\/j.1600-6143.2004.00592.x","article-title":"A seroprevalence study of West Nile virus infection in solid organ transplant recipients","volume":"4","author":"Kumar","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib31","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1086\/383325","article-title":"West Nile virus-associated encephalitis in recipients of renal and pancreas transplants: case series and literature review","volume":"38","author":"Ravindra","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1399-0012.2009.01044.x","article-title":"Impact of rituximab-associated B-cell defects on West Nile virus meningoencephalitis in solid organ transplant recipients","volume":"24","author":"Levi","year":"2010","journal-title":"Clin Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib33","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/archneur.61.8.1210","article-title":"Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features","volume":"61","author":"Kleinschmidt-DeMasters","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1017\/S0317167100053749","article-title":"Therapy of West Nile virus infection","volume":"31","author":"Jackson","year":"2004","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1086\/376870","article-title":"Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice","volume":"188","author":"Ben-Nathan","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib36","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1053\/j.ajkd.2008.03.042","article-title":"West Nile virus encephalitis in a renal transplant recipient: the role of intravenous immunoglobulin","volume":"52","author":"Saquib","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib37","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1128\/JVI.77.4.2578-2586.2003","article-title":"B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus","volume":"77","author":"Diamond","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib38","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/1471-2334-14-248","article-title":"West Nile virus neuroinvasive disease: neurological manifestations and prospective longitudinal outcomes","volume":"14","author":"Hart","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib39","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1086\/427945","article-title":"Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases","volume":"40","author":"Kalil","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib40","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/ajt.12666","article-title":"Considerations for screening live kidney donors for endemic infections: a viewpoint on the UNOS policy","volume":"14","author":"Levi","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib41","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1111\/ajt.12849","article-title":"Donor-transmitted HTLV-1-associated myelopathy in a kidney transplant recipient--case report and literature review","volume":"14","author":"Ramanan","year":"2014","journal-title":"Am J Transplant"},{"issue":"Suppl 4","key":"10.1016\/j.semnephrol.2016.05.019_bib42","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/ajt.12127","article-title":"Human T cell lymphotrophic virus 1\/2 in solid organ transplantation","volume":"13","author":"Kaul","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib43","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1600-6143.2009.02867.x","article-title":"Donor screening for human T-cell lymphotrophic virus 1\/2: changing paradigms for changing testing capacity","volume":"10","author":"Kaul","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib44","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jama.284.2.229","article-title":"Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS)","volume":"284","author":"Glynn","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib45","first-page":"189","article-title":"Human T lymphotropic virus 1-2 positive antibodies in potential organ donors in France","volume":"28","author":"Claquin","year":"1996","journal-title":"Transplant Proc"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib46","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1056\/NEJMoa032510","article-title":"Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States","volume":"351","author":"Zou","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib47","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00007890-200301150-00019","article-title":"Rapid development of subacute myelopathy in three organ transplant recipients after transmission of human T-cell lymphotropic virus type I from a single donor","volume":"75","author":"Toro","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib48","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/mus.24450","article-title":"HTLV-1-associated myelopathy\/tropical spastic paraparesis and peripheral neuropathy following live-donor renal transplantation","volume":"51","author":"Younger","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib49","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1046\/j.1537-2995.2000.40111421.x","article-title":"Transmission of HTLV-I by kidney transplant","volume":"40","author":"Remesar","year":"2000","journal-title":"Transfusion"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib50","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/S0041-1345(98)00261-9","article-title":"Influence of immunosuppression in HTLV-1-positive renal transplant recipients","volume":"30","author":"Nakamura","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib51","first-page":"695","article-title":"HTLV-1 T cell lymphoma in a cyclosporine-treated renal transplant patient","volume":"48","author":"Zanke","year":"1989","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib52","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.transproceed.2005.03.132","article-title":"Prognosis of HTLV-I-positive renal transplant recipients","volume":"37","author":"Nakamura","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib53","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.transproceed.2011.11.021","article-title":"Renal transplantation in patients with human T-cell lymphotropic virus type 1","volume":"44","author":"Shirai","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib54","first-page":"670","article-title":"Prognosis of HTLV-1 positive renal transplant recipients in Iran","volume":"22","author":"Naghibi","year":"2011","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib55","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/clinids\/21.4.992","article-title":"Development of human T-cell lymphotropic virus type I-associated adult T-cell leukemia\/lymphoma during immunosuppressive treatment following renal transplantation","volume":"21","author":"Jenks","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib56","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jcv.2015.09.010","article-title":"HTLV-1 associated myelopathy after renal transplantation","volume":"72","author":"Govert","year":"2015","journal-title":"J Clin Virol"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib57","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/cid\/cit545","article-title":"Delayed seroconversion and rapid onset of lymphoproliferative disease after transmission of human T-cell lymphotropic virus type 1 from a multiorgan donor","volume":"57","author":"Glowacka","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib58","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1125>3.0.CO;2-N","article-title":"Lymphoproliferative disorders in renal transplant patients in Japan","volume":"91","author":"Hoshida","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib59","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/00042560-199909010-00012","article-title":"Prospective study of HTLV-I infection in an initially asymptomatic cohort","volume":"22","author":"Taylor","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib60","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1526-0968.2001.00398.x","article-title":"Plasma exchange for the treatment of human T-cell lymphotropic virus type 1 associated myelopathy","volume":"5","author":"Narukawa","year":"2001","journal-title":"Ther Apher"},{"key":"10.1016\/j.semnephrol.2016.05.019_bib61","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/ajt.13146","article-title":"Donor-derived HTLV-1 associated myelopathy after transplantation: a call for targeted screening","volume":"15","author":"Ramanan","year":"2015","journal-title":"Am J Transplant"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027092951630050X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027092951630050X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T22:28:07Z","timestamp":1657492087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027092951630050X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S027092951630050X"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2016.05.019","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Not the Usual Viral Suspects: Parvovirus B19, West Nile Virus, and Human T-Cell Lymphotrophic Virus Infections After Kidney Transplantation","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2016.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}